Pancreatic Cancer Research

ResearcherUniversity of Colorado Cancer CenterActive in the last 2 years

Ana Gleisner

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5040-4105; OpenAlex author ID A5017902361. Sources: ClinicalTrials.gov.

Their work

Papers
12 (first author 2, last author 1)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
31
Papers, trials and grants by year

2018: 3 papers · 2019: none · 2020: none · 2021: 1 paper · 2022: 2 papers, 1 trial · 2023: 2 papers · 2024: 3 papers · 2025: none · 2026: 1 paper

Papers 12

  1. Patterns of treatment and survival in borderline resectable and locally advanced pancreatic cancer. Co-author DOI 10.1016/j.pan.2025.12.007↗
  2. Gaining a new angle on pancreas cancer: A pre-operative thrombelastographic parameter predicts recurrence and survival among patients with resected periampulla… Last author DOI 10.1016/j.amjsurg.2024.115820↗
  3. Characteristics and prognosis of patients with pancreatic adenocarcinoma not expressing CA19-9: Analysis of the National Cancer Database. Co-author DOI 10.1016/j.pan.2024.11.011↗
  4. Neoadjuvant Chemotherapy Versus Upfront Surgery for Resectable Pancreatic Adenocarcinoma: An Updated Nationwide Study. Co-author DOI 10.1097/sla.0000000000005925↗
  5. Association of Adjuvant Chemotherapy in Patients With Resected Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy. Co-author DOI 10.1001/jamaoncol.2022.5808↗
  6. Pulmonary metastasectomy is associated with survival after lung-only recurrence in pancreatic cancer. Co-author DOI 10.1016/j.surg.2023.05.008↗
  7. Comparing neoadjuvant chemotherapy with or without radiation therapy for pancreatic ductal adenocarcinoma: National Cancer Database cohort analysis. Co-author DOI 10.1093/bjs/znac002↗
  8. Prognosis Based Definition of Resectability in Pancreatic Cancer: A Road Map to New Guidelines. Co-author DOI 10.1097/sla.0000000000003859↗
  9. Outcome of neoadjuvant treatment for pancreatic cancer in elderly patients: comparative, observational cohort study. Co-author DOI 10.1093/bjs/znab092↗
  10. Perioperative outcomes and survival following neoadjuvant stereotactic body radiation therapy (SBRT) versus intensity-modulated radiation therapy (IMRT) in pan… First author DOI 10.1002/jso.25004↗
  11. Comparison of laparoscopic to open pancreaticoduodenectomy in elderly patients with pancreatic adenocarcinoma. Co-author DOI 10.1007/s00464-017-5915-0↗
  12. Perioperative and Survival Outcomes Following Neoadjuvant FOLFIRINOX versus Gemcitabine Abraxane in Patients with Pancreatic Adenocarcinoma. First author PMID 29950957↗

Trials 1

  1. Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection Principal investigator NCT05517811↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Richard David Schulick · 12 shared papers, 2018–2026 · strength 1.86
  2. Marco Del Chiaro · 8 shared papers, 2021–2026 · strength 1.47
  3. Toshitaka Sugawara · 5 shared papers, 2023–2026 · strength 1.02
  4. Oskar Franklin · 3 shared papers, 2024–2026 · strength 0.68
  5. Jun Ishida · 3 shared papers, 2023–2024 · strength 0.56
  6. Samuele Grandi · 3 shared papers, 2023–2024 · strength 0.56
  7. Martin D. McCarter · 4 shared papers, 2018–2024 · strength 0.45
  8. Barish H. Edil · 4 shared papers, 2018–2024 · strength 0.45
  9. Atsushi Oba · 3 shared papers, 2021–2022 · strength 0.39
  10. Robert J. Torphy · 2 shared papers, 2022–2024 · strength 0.35
  11. Wells A. Messersmith · 3 shared papers, 2018–2023 · strength 0.34
  12. Asif Halimi · 1 shared paper, 2026 · strength 0.29
  13. Thomas F. Stoop · 1 shared paper, 2026 · strength 0.29
  14. Hiroyuki Ishida · 1 shared paper, 2026 · strength 0.29
  15. Christopher Hanyoung Lieu · 2 shared papers, 2021–2023 · strength 0.26
  16. Sana D. Karam · 2 shared papers, 2021–2022 · strength 0.24
  17. Brandon C. Chapman · 3 shared papers, 2018 · strength 0.24
  18. Csaba Gajdos · 3 shared papers, 2018 · strength 0.24
  19. Alexander C. Schulick · 1 shared paper, 2024 · strength 0.21
  20. Hunter B. Moore · 1 shared paper, 2024 · strength 0.21
  21. Karyn A. Goodman · 2 shared papers, 2018–2021 · strength 0.18
  22. Christina M. Stuart · 1 shared paper, 2023 · strength 0.17
  23. Robert Alexander Meguid · 1 shared paper, 2023 · strength 0.17
  24. Alessandro Paniccia · 2 shared papers, 2018 · strength 0.16
  25. Marco Del Chiaro · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.